Causes and Consequences of Increased Sympathetic Activity in Renal Disease

No abstract is available for this paper.

• Publication year

  2004

• Venue

  HYPERTENSION

• Publication date

  2004-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.HYP.0000121881.77212.b1PMID 14981063
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Leptin and Renal Disease

  2006cited by this paper
• Pathophysiology of contrast medium-induced nephropathy.

  2005cited by this paper
• Anti-monocyte chemoattractant protein-1 gene therapy attenuates renal injury induced by protein-overload proteinuria

  2004cited by this paper
• Third-Generation &bgr;-Blockers Stimulate Nitric Oxide Release From Endothelial Cells Through ATP Efflux: A Novel Mechanism for Antihypertensive Action

  2003cited by this paper
• Renoprotection by ACE Inhibition or Aldosterone Blockade Is Blood Pressure–Dependent

  2003cited by this paper
• Spectrum of mutations in the gene for autosomal recessive polycystic kidney disease (ARPKD/PKHD1).

  2003cited by this paper
• Neural regulation of blood pressure by leptin and the related peptides.

  2003cited by this paper
• Moxonidine treatment of hypertensive patients with advanced renal failure

  2003cited by this paper
• Relation Between Cardiac Sympathetic Activity and Hypertensive Left Ventricular Hypertrophy

  2003cited by this paper
• Impact of renal denervation on renal content of GLUT1, albuminuria and urinary TGF-beta1 in streptozotocin-induced diabetic rats.

  2003cited by this paper
• Cell biology of the glomerular podocyte.

  2003cited by this paper
• Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial.

  2003cited by this paper
• Hypertension and Left Ventricular Hypertrophy : The 4 E Effects of Eplerenone , Enalapril , and Eplerenone / Enalapril in Patients With Essential

  2003cited by this paper
• Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model.

  2003cited by this paper
• Anti-monocyte chemoattractant protein-1 gene therapy attenuates renal injury induced by protein-overload proteinuria.

  2003cited by this paper
• Simvastatin Normalizes Autonomic Neural Control in Experimental Heart Failure

  2003cited by this paper
• Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community.

  2003cited by this paper
• Paradoxes of nitric oxide in the diabetic kidney.

  2003cited by this paper
• Effect of blockade of endogenous angiotensin II on baroreflex function in conscious diabetic rats.

  2003cited by this paper
• Patterns of care for patients with chronic kidney disease in the United States: dying for improvement.

  2003cited by this paper
• Antihypertensive therapy in chronic renal disease: a place for sympathicolytic agents?

  2003cited by this paper
• A Nitric Oxide-Generating Beta-Blocking Agent Prevents Renal Injury in the Rat Remnant Kidney Model

  2003cited by this paper
• Diuretic Versus &agr;-Blocker as First-Step Antihypertensive Therapy: Final Results From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

  2003cited by this paper
• Cigarette smoke condensate aggravates renal injury in the renal ablation model.

  2002cited by this paper
• Alpha(1)-adrenoceptor stimulation directly induces growth of vascular wall in vivo.

  2002cited by this paper
• Proteinuria is preceded by decreased nitric oxide synthesis and prevented by a NO donor in cholesterol-fed rats.

  2002cited by this paper
• Attenuation of Hypertension, Cardiomyocyte Hypertrophy, and Myocardial Fibrosis by &bgr;-Adrenoceptor Blockers in Rats Under Long-term Blockade of Nitric Oxide Synthesis

  2002cited by this paper
• Purinergic Signaling and Vascular Cell Proliferation and Death

  2002cited by this paper
• The Renin-Angiotensin System and Progression of Renal Disease: From Hemodynamics to Cell Biology

  2002cited by this paper
• Nipradilol prevents L-NAME-exacerbated nephrosclerosis with decreasing of caspase-3 expression in SHR.

  2002cited by this paper
• Association of Renal Insufficiency with Treatment and Outcomes after Myocardial Infarction in Elderly Patients

  2002cited by this paper
• Goodpasture syndrome during the course of a Schönlein-Henoch purpura.

  2002cited by this paper
• Reduced nitric oxide synthase activity in rats with chronic renal disease due to glomerulonephritis.

  2002cited by this paper
• Hypertension in L-NAME-treated diabetic rats depends on an intact sympathetic nervous system.

  2002cited by this paper
• A role for uric acid in the progression of renal disease.

  2002cited by this paper
• Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure: Results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study

  2002cited by this paper
• Sympathetic Nerve Activity in End-Stage Renal Disease

  2002cited by this paper
• Chronic alpha1-adrenergic blockade improves hypertension and renal injury in L-NAME and low-renin L-NAME-DOCA hypertensive rats.

  2002cited by this paper
• Leptin and renal disease.

  2002cited by this paper
• Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity.

  2002cited by this paper
• Role of the microvascular endothelium in progressive renal disease.

  2002cited by this paper
• Effect of Methyldopa on Renal Function in Rats with L-NAME-Induced Hypertension in Pregnancy

  2001cited by this paper
• Lowering of microalbuminuria in diabetic patients by a sympathicoplegic agent: novel approach to prevent progression of diabetic nephropathy?

  2001cited by this paper
• P2 receptors in regulation of renal microvascular function.

  2001cited by this paper
• Different effects of angiotensin II and catecholamine on renal cell apoptosis and proliferation in rats.

  2001cited by this paper
• Renoprotective effects of carvedilol in hypertensive‐stroke prone rats may involve inhibition of TGFβ expression

  2001cited by this paper
• Intrarenal angiotensin and bradykinin peptide levels in the remnant kidney model of renal insufficiency.

  2001cited by this paper
• Glomerulosclerosis and progression: effect of subantihypertensive doses of alpha and beta blockers.

  2001cited by this paper
• Glomerulosclerosis and progression: Effect of subantihypertensive doses of α and βblockers

  2001cited by this paper
• Trophic Effect of Norepinephrine on Arterial Intima-Media and Adventitia Is Augmented by Injury and Mediated by Different &agr;1-Adrenoceptor Subtypes

  2001cited by this paper
• Progression, remission, regression of chronic renal diseases.

  2001cited by this paper
• Obesity hypertension: role of leptin and sympathetic nervous system.

  2001cited by this paper
• Obesity-related glomerulopathy: an emerging epidemic.

  2001cited by this paper
• Central Hypotensive Action of Clonidine Requires Nitric Oxide

  2001cited by this paper
• Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure.

  2001cited by this paper
• Sympathetic activity is increased in polycystic kidney disease and is associated with hypertension.

  2001cited by this paper
• Extracellular nucleotide signaling along the renal epithelium.

  2001cited by this paper
• Sympathetic nervous system and insulin resistance: from obesity to diabetes.

  2001cited by this paper
• Losartan versus enalapril on cerebral edema and proteinuria in stroke-prone hypertensive rats.

  2001cited by this paper
• Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes.

  2001cited by this paper
• Combined mycophenolate mofetil and losartan therapy arrests established injury in the remnant kidney.

  2000cited by this paper
• Effect of antihypertensive therapy on renal injury in type 2 diabetic rats with hypertension.

  2000cited by this paper
• Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats.

  2000cited by this paper
• Sympathetic overactivity in renal disease: a window to understand progression and cardiovascular complications of uraemia?

  2000cited by this paper
• Carvedilol: a beta blocker with antioxidant property protects against gentamicin-induced nephrotoxicity in rats.

  2000cited by this paper
• Transforming growth factor-beta 1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction.

  2000cited by this paper
• Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes.

  2000cited by this paper
• Lack of evidence of blood pressure-independent protection by renin-angiotensin system blockade after renal ablation.

  2000cited by this paper
• Heme oxygenase-1 is upregulated in the kidney of angiotensin II-induced hypertensive rats : possible role in renoprotection.

  2000cited by this paper
• Transforming growth factor-β1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction

  2000cited by this paper
• Renal injury and salt-sensitive hypertension after exposure to catecholamines.

  1999cited by this paper
• Mechanisms of antihyperglycemic effects of moxonidine in the obese spontaneously hypertensive Koletsky rat (SHROB).

  1999cited by this paper
• Effects of alacepril and amlodipine on the renal injury induced by a high-cholesterol diet in rats.

  1999cited by this paper
• Renoprotection by nitric oxide donor and lisinopril in the remnant kidney model.

  1999cited by this paper
• Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure.

  1999cited by this paper
• ACE-I vs angiotensin II receptor antagonists: prevention of renal injury in chronic rat models

  1999cited by this paper
• Losartan-sensitive renal damage caused by chronic NOS inhibition does not involve increased renal angiotensin II concentrations.

  1999cited by this paper
• Angiotensin II, nitric oxide, and end-organ damage in hypertension.

  1998cited by this paper
• The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)

  1998cited by this paper
• Carvedilol prevents severe hypertensive cardiomyopathy and remodeling

  1998cited by this paper
• Nitric oxide (NO) modulates the neurogenic control of blood pressure in rats with chronic renal failure (CRF).

  1997cited by this paper
• Reflex influences on renal nerve activity characteristics in nephrosis and heart failure.

  1997cited by this paper
• Neural control of renal function.

  1997cited by this paper
• Serum levels of NG, NG-dimethyl-L-arginine, a potential endogenous nitric oxide inhibitor in dialysis patients.

  1997cited by this paper
• Renal and systemic nitric oxide synthesis in rats with renal mass reduction.

  1997cited by this paper
• Carvedilol protects against glomerulosclerosis in rat remnant kidney without general changes in antioxidant enzyme status. A comparative study of two beta-blocking drugs, carvedilol and propanolol.

  1997cited by this paper
• Effects of the novel multiple-action agent carvedilol on severe nephrosclerosis in renal ablated rats.

  1997cited by this paper
• Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients.

  1997cited by this paper
• Effects of antihypertensive drugs on nitric oxide synthase activity in rat kidney.

  1996cited by this paper
• Arteriolar wall thickening, capillary rarefaction and interstitial fibrosis in the heart of rats with renal failure:the effects of ramipril, nifedipine and moxonidine.

  1996cited by this paper
• Renal denervation prevents intraglomerular platelet aggregation and glomerular injury induced by chronic inhibition of nitric oxide synthesis.

  1996cited by this paper
• Doxazosin prevents proteinuria and glomerular loss of heparan sulfate in diabetic rats.

  1996cited by this paper
• Chronic carvedilol reduces mortality and renal damage in hypertensive stroke-prone rats.

  1996cited by this paper
• Effects of antihypertensive therapy on blood pressure and renal function in rats with hypertension due to chronic blockade of nitric oxide synthesis.

  1995cited by this paper
• Effects of chronic NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous system.

  1995cited by this paper
• Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat.

  1995cited by this paper
• Volume regulation in children with early relapse of minimal-change nephrosis with or without hypovolaemic symptoms.

  1995cited by this paper
• Comparative study of the effect of ACE-inhibitors and other antihypertensive agents on proteinuria in diabetic patients.

  1994cited by this paper
• Hypertension induced by nitric oxide synthesis inhibition is renal nerve dependent.

  1994cited by this paper
• Muscle Sympathetic Nerve Activity Is Reduced in IDDM Before Overt Autonomic Neuropathy

  1993cited by this paper

• Relationships of Isolated Nocturnal Hypertension with Glomerular Filtration Rate and Albuminuria

  2025cites this paper
• Cardiorenal Syndrome and Autonomic Overactivity

  2025cites this paper
• Blood Pressure Variability and End‐Stage Kidney Disease Among Individuals With Type 2 Diabetes: A Nationwide Cohort Study

  2025cites this paper
• Endovascular renal denervation for the treatment of hypertension

  2025cites this paper
• Renal nerve afferents drive preferential renal sympathoexcitation in response to acute renal ischemia/reperfusion in rats.

  2025cites this paper
• Cardiorenal Benefits of SGLT2 Inhibitors in Patients with Chronic Kidney Disease and Concomitant Hypertension

  2025cites this paper
• The impact of chronic kidney disease on prognosis in acute stroke: unraveling the pathophysiology and clinical complexity for optimal management

  2024cites this paper
• Quercetin supplementation prevents kidney damage and improves long‐term prognosis in hypertensive patients

  2024cites this paper
• Association between blood pressure variability and risk of kidney function decline in hypertensive patients without chronic kidney disease: a post hoc analysis of Systolic Blood Pressure Intervention Trial study

  2024cites this paper
• Evaluation of Right Ventricular Function in Chronic Renal Failure Patients on Regular Hemodialysis Therapy (Tissue Doppler Imaging Study)

  2023cites this paper
• Obesity-related glomerulopathy in children: connecting pathophysiology to clinical care

  2022cites this paper
• Renalase: a novel regulator of cardiometabolic and renal diseases

  2022cites this paper
• Obesity-Related Glomerulopathy: From Mechanism to Therapeutic Target

  2021cites this paper
• Assessment of Renalase Levels in End-Stage Renal Disease Patients on Maintenance Hemodialysis

  2021cites this paper
• Catecholamines production by kidney tissue and mesangial cell culture is differentially modulated by diabetes

  2021cites this paper
• Noise-Induced Vascular Dysfunction, Oxidative Stress, and Inflammation Are Improved by Pharmacological Modulation of the NRF2/HO-1 Axis

  2021cites this paper
• Capillary Rarefaction in Obesity and Metabolic Diseases—Organ-Specificity and Possible Mechanisms

  2020cites this paper
• Range of adiposity and cardiorenal syndrome

  2020cites this paper
• The effect of osteopathic manual therapy with breathing retraining on cardiac autonomic measures and breathing symptoms scores: A randomised wait-list controlled trial.

  2020cites this paper
• Nonpharmacological therapies for uncontrolled hypertension

  2020cites this paper
• Heart rate and blood pressure is associated with renal function in patients with type 1 diabetes in the absence of nephropathy and therapeutical interventions

  2019cites this paper
• Association Between Systolic and Diastolic Blood Pressure Variability and the Risk of End-Stage Renal Disease

  2019cites this paper
• The Effects of Breviscapine Injection on Hypertension in Hypertension-Induced Renal Damage Patients: A Systematic Review and a Meta-Analysis

  2019cites this paper
• Left ventricular systolic dysfunction in pediatric chronic kidney disease patients

  2019influential citation
• Neural control of cardiovascular function in Black adults: implications for racial differences in autonomic regulation.

  2019cites this paper
• Baseline High Blood Pressure is Associated with Clinico-Pathologic Findings and Later Renal Progression in Chronic Glomerulonephritis

  2019cites this paper
• Hypertensive Chronic Kidney Disease

  2019cites this paper
• Hypertensive emergencies in diabetic patients from predominantly African American urban communities

  2018cites this paper
• Protective Effect of Gastric Distension Preconditioning on Renal Ischemia/Reperfusion Injury in Rats

  2018cites this paper
• Heart Rate Variability and Its Relation to Chronic Kidney Disease: Results From the PREVEND Study

  2018cites this paper
• Multimodality Imaging in Patients with Secondary Hypertension: With a Focus on Appropriate Imaging Approaches Depending on the Etiologies

  2018cites this paper
• Synergistical action of the β2 adrenoceptor and fatty acid binding protein 2 polymorphisms on the loss of glomerular filtration rate in Chinese patients with type 2 diabetic nephropathy

  2018cites this paper
• Decreased heart rate variability is associated with declined renal function in hypertensive patients

  2018cites this paper
• Efeitos de uma sessão de exercício aeróbico nas variáveis hemodinâmicas, neurais e inflamatórias de pacientes com doença renal crônica e sua relação com o polimorfismo da gene da ECA

  2018cites this paper
• Baroreflex stimulation for treating resistant hypertension: ready for the prime-time?

  2018cites this paper
• Endovascular Baroreflex Amplification for Resistant Hypertension

  2018cites this paper
• Renalase gene polymorphisms (rs2576178 and rs10887800) in Egyptian hypertensive end stage renal disease patients

  2018cites this paper
• 33 – Hypertension and Chronic Kidney Disease

  2018cites this paper
• Combined Therapy of Hypertensive Nephropathy with Breviscapine Injection and Antihypertensive Drugs: A Systematic Review and a Meta-Analysis

  2018cites this paper
• Sympathetic overactivity in dialysis patients—Underappreciated and clinically consequential

  2018cites this paper
• DASS21: A Useful Tool in the Psychological Profile Evaluation of Dialysis Patients

  2017cites this paper
• Differential gene and lncRNA expression in the lower thoracic spinal cord following ischemia/reperfusion-induced acute kidney injury in rats

  2017cites this paper
• Pathophysiological Insights of Hypertension in Patients with Chronic Kidney Disease

  2017cites this paper
• Differential gene and lncRNA expression in the lower thoracic spinal cord following ischemia/reperfusion-induced acute kidney injury in rats.

  2017cites this paper
• NEUROMODULATION VA CATHETER APPARATUSES HAVING EXPANDABLE BASKETS

  2017cites this paper
• The role of renal sympathetic nerves in ischemia reperfusion injury.

  2017cites this paper
• Brain natriuretic peptide as a potential novel marker of salt-sensitivity in chronic kidney disease patients without cardiac dysfunction

  2017cites this paper
• Pathogenetic Pathways of Cardiorenal Syndrome and their Possible Therapeutic Implications.

  2016cites this paper
• Increased Blood Pressure Variability Prior to Chronic Kidney Disease Exacerbates Renal Dysfunction in Rats

  2016cites this paper
• Left Ventricular Systolic Dysfunction in Patients with Chronic Kidney Disease

  2016cites this paper
• Hyponatremia is Associated with Fluid Imbalance and Adverse Renal Outcome in Chronic Kidney Disease Patients Treated with Diuretics

  2016cites this paper
• Effects of Renal Denervation on Chronic Kidney Disease

  2016cites this paper
• Free Radicals and Biomarkers Related to the Diagnosis of Cardiorenal Syndrome

  2016cites this paper
• Role of the Renal Microcirculation in Progression of Chronic Kidney Injury in Obesity

  2016cites this paper
• Chronic Kidney Disease As a Potential Indication for Renal Denervation

  2016cites this paper
• Post-Exercise Hypotension Is Mediated by a Decrease in Sympathetic Nerve Activity in Stages 2-3 CKD

  2016cites this paper
• Cardiac Autonomic Dysfunction Is Associated With High-Risk Albumin-to-Creatinine Ratio in Young Adolescents With Type 1 Diabetes in AdDIT (Adolescent Type 1 Diabetes Cardio-Renal Interventional Trial)

  2015cites this paper
• The Cardio-renal Syndrome (CRS)

  2015cites this paper
• Detection of Autonomic Dysfunction in Hemodialysis Patients Using the Exercise Treadmill Test: The Role of the Chronotropic Index, Heart Rate Recovery, and R-R Variability

  2015cites this paper
• Hypertension in Chronic Glomerulonephritis

  2015cites this paper
• Heart Rate Variability Correlates to Functional Aerobic Impairment in Hemodialysis Patients

  2015cites this paper
• Technical aspects of renal denervation in end-stage renal disease patients with challenging anatomy.

  2014cites this paper
• Cardiac autonomic neuropathy in patients with diabetes mellitus.

  2014cites this paper
• Cardiorenal syndrome—current understanding and future perspectives

  2014cites this paper
• Angiotensin II, sympathetic nerve activity and chronic heart failure

  2014cites this paper
• Cardiac autonomic neuropathy predicts renal function decline in patients with type 2 diabetes: a cohort study

  2014cites this paper
• Sympathetic activation secondary to chronic kidney disease: therapeutic target for renal denervation?

  2014cites this paper
• The effect of abnormal birth history on ambulatory blood pressure and disease progression in children with chronic kidney disease.

  2014cites this paper
• Heart rate and blood pressure variability in children with chronic kidney disease: a report from the CKiD study

  2014cites this paper
• The blood pressure-lowering effect of renal denervation is inversely related to kidney function

  2014cites this paper
• Étude de l’expression de « Bcl-2 modifying factor » (Bmf) et son implication dans la néphropathie diabétique

  2014cites this paper
• Hipertansif hastalarda N- amino terminal prohormon beyin natriüretik peptid düzeyleri ile ilişkili faktörler Factors associated with the levels of N- amino terminal prohormone brain natriuretic peptid in hypertensive population

  2014cites this paper
• Left ventricular function and chronic kidney disease: how soon does it start?

  2014cites this paper
• Vasoconstriction vascular effects Insulin resistance Kidney injury / ischemia Hypertrophy Arrhythmia Oxygen consumption Renal afferent nerves h Renin release g RAS activation h Sodium retention i Renal blood flow h Proteinuria h Glomerulosclerosis

  2014cites this paper
• The role of sympathetic nervous system in the progression of chronic kidney disease in the era of catheter based sympathetic renal denervation.

  2013cites this paper
• Effectiveness of renal denervation therapy for resistant hypertension: a systematic review and meta-analysis.

  2013cites this paper
• Obesity-related glomerulopathy and the nephron complement.

  2013cites this paper
• Chronic kidney disease: role of sympathetic nervous system activation and potential benefits of renal denervation.

  2013cites this paper
• Blood pressure-renal blood flow relationships in conscious angiotensin II- and phenylephrine-infused rats.

  2013cites this paper
• Chapter 30 – Kidney Disease in Hypertension

  2013cites this paper
• Therapeutic effects of renal denervation on renal failure.

  2013cites this paper
• Association of E/E′ and NT-proBNP with Renal Function in Patients with Essential Hypertension

  2013cites this paper
• Risk factors of cardiovascular disease among children with chronic kidney disease in Gaza strip

  2012cites this paper
• Cardiovascular disease: Should statin therapy be expanded in patients with CKD?

  2012cites this paper
• Renin-angiotensin system, hypertension, and chronic kidney disease: pharmacogenetic implications.

  2012cites this paper
• Polymorphism of the renalase gene in end-stage renal disease patients affected by hypertension.

  2012cites this paper
• Renal Protection in Hypertensive Patients: Selection of Antihypertensive Therapy

  2012influential citation
• Renal nerves and CKD: is renal denervation the answer?

  2012cites this paper
• Hypertension: Renal denervation in chronic kidney disease

  2012cites this paper
• Cardioprotective Effect of Renalase in 5/6 Nephrectomized Rats

  2012cites this paper
• Heart Rate Variability in Peritoneal Dialysis Patients: What Is the Role of Residual Renal Function?

  2012cites this paper
• Evidence and Consequences of the Central Role of the Kidneys in the Pathophysiology of Sympathetic Hyperactivity

  2012cites this paper
• Cardiovascular Risk in Chronic Kidney Disease: Role of the Sympathetic Nervous System

  2012cites this paper
• Cardiovascular and Renal Complications in Obesity and Obesity-Related Medical Conditions: Role of Sympathetic Nervous Activity and Insulin Resistance

  2012cites this paper
• Renal sympathetic nervous system hyperactivity in early streptozotocin‐induced diabetic kidney disease

  2011influential citation
• Atorvastatin reduces sympathetic activity in patients with chronic kidney disease

  2011cites this paper
• Podocyte dysfunction in aging--related glomerulosclerosis.

  2011cites this paper
• Characterization of renal hemodynamic and structural alterations in rat models of renal impairment: role of renal sympathoexcitation.

  2011cites this paper
• Relationships of Adrenoceptor Polymorphisms with Obesity

  2011cites this paper
• Renal dysfunction prevalence and clinical impact in heart failure

  2011cites this paper